Following the Global Perspectives on Early-Stage Investment & Partnering event on October 3, 2018, Novateur Ventures and Accel-Rx organized a unique networking opportunity for an exclusive group of Canadian entrepreneurs and innovators in Life Sciences and key strategists and foreign investors.
The mountain adventure began the morning of the October 4th, with transportation to Squamish airport for a helicopter flight through glacial peaks to a remote corner of the Coastal Range.
A hike through the alpine meadows of British Columbia’s back country, along granite ridges and past inviting pools ended with lunch overlooking the deep ocean fjords. The hike presented participants with an opportunity to build mutually beneficial relationships with one-another in the hopes of bolstering Canada’s endeavors in Life Sciences and Biotechnology.
Participants of this amazing experience included:
Alex Szidon, PhD, Head, West Coast Innovation Hub and Associate VP Business Development – Licensing, Merck
Asish K. Xavier, PhD, MBA, VP, Venture Investments, Johnson & Johnson Innovation – JJDC
Wenkai Vincent Xiang, PhD, MBA, Hillhouse Capital
Forest (Tianhong) Xu, MD, PhD, Partner, Virtus Inspire Ventures
Thomas Michael Thestrup, PhD, Associate Director, Global Business Development at UCB
Arthur Tinkelenberg, PhD, Executive Director, Torreya Capital
Ali Ardakani, Founder & Managing Director of Novateur Ventures
Daniel Wattier, CEO of ImStar Therapeutics
David Young, MD, Founder & CEO of KisoJi Biotechnology
Eric Zimmerman, Head Global Venture Capital Financing at Novateur Ventures
Frédéric Leduc, CEO of Immune Biosolutions
Frederic Lemaitre Auger, Senior Director, Investments at Accel-Rx
George Aliphtiras, CEO of Sonic Incytes Medical Corporation
Jeffrey Coull, President & CEO of Encycle Therapeutics
Michael Lincoln, Chief Financial and Business Officer of Accel-Rx
Oliver Buck, Founder of ITM AG
Pierre Beauparlant, President & CEO of SpecificiT Pharma
William Jia, CSO & Co-founder of Virogin Biotech